news
Wellness shot brand Dose explores sale, could fetch $100M
Wellness shot brand Dose, known for its elderberry, turmeric, and ginger shots, is reportedly exploring a sale that could value the company at over $100 million. The company markets these shots for liver, cholesterol, and skin health. This signals continued investor interest in ingestible wellness.
Wellness shot brand Dose, known for its elderberry, turmeric, and ginger shots, is reportedly exploring a sale that could value the company at over $100 million. The company markets these shots for liver, cholesterol, and skin health. This signals continued investor interest in ingestible wellness.
The architecture take
Another day, another wellness brand looking for a big exit. Dose, with its elderberry and ginger shots, is aiming for a $100M valuation, which feels like a lot for something that's basically spiced juice in a tiny bottle. I get the appeal – easy way to feel like you're doing something good for your body, hitting those immunity and anti-inflammatory notes without thinking too hard. But what are you actually paying for here? Mostly convenience and the brand story, I suspect. The real play is the perceived benefit to your gut and immune system, which is a massive market. Investors know people are still shelling out for 'health in a bottle' narratives, even if the science is often more nuanced than the marketing. Watch for more consolidation in the functional beverage space; everyone wants to own a piece of your morning routine.